Condensed Consolidated Interim Financial Statements as of September 30, 2018

Bayer Group
Consolidated Statements of Changes in Equity

 

 

Capital stock

 

Capital reserves

 

Other reserves

 

Equity attributable to Bayer AG stockholders

 

Equity attributable to non-controlling interest

 

Equity

 

 

€ million

 

€ million

 

€ million

 

€ million

 

€ million

 

€ million

Dec. 31, 2016

 

2,117

 

9,658

 

18,558

 

30,333

 

1,564

 

31,897

Equity transactions with owners

 

 

 

 

 

 

 

 

 

 

 

 

Capital increase / decrease

 

 

 

 

 

 

 

 

 

 

 

 

Dividend payments

 

 

 

 

 

(2,233)

 

(2,233)

 

(131)

 

(2,364)

Other changes

 

 

 

 

 

2,723

 

2,723

 

(2,025)

 

698

Total comprehensive income

 

 

 

 

 

6,373

 

6,373

 

650

 

7,023

Sep. 30, 2017

 

2,117

 

9,658

 

25,421

 

37,196

 

58

 

37,254

Dec. 31, 2017

 

2,117

 

9,658

 

25,026

 

36,801

 

60

 

36,861

Adjustment of retained earnings on adoption of IFRS 9 (net of tax)

 

 

 

 

 

(60)

 

(60)

 

 

 

(60)

Adjustment of retained earnings on adoption of IFRS 15 (net of tax)

 

 

 

 

 

86

 

86

 

 

 

86

Equity transactions with owners

 

 

 

 

 

 

 

 

 

 

 

 

Capital increase / decrease

 

270

 

8,730

 

 

 

9,000

 

 

 

9,000

Dividend payments

 

 

 

 

 

(2,402)

 

(2,402)

 

(3)

 

(2,405)

Other changes

 

 

 

 

 

(6)

 

(6)

 

118

 

112

Total comprehensive income

 

 

 

 

 

6,826

 

6,826

 

(3)

 

6,823

Sep. 30, 2018

 

2,387

 

18,388

 

29,470

 

50,245

 

172

 

50,417

Compare to Last Year